Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $27.3 million.

  • Camp4 Therapeutics' Shares Outstanding (Weighted Average) rose 479287.96% to $27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.3 million, marking a year-over-year increase of 479287.96%. This contributed to the annual value of $4.7 million for FY2024, which is 108743.77% up from last year.
  • As of Q3 2025, Camp4 Therapeutics' Shares Outstanding (Weighted Average) stood at $27.3 million, which was up 479287.96% from $20.2 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $27.3 million in Q3 2025 and a low of $394976.0 during Q4 2023
  • Over the past 3 years, Camp4 Therapeutics' median Shares Outstanding (Weighted Average) value was $557437.0 (recorded in 2024), while the average stood at $8.3 million.
  • As far as peak fluctuations go, Camp4 Therapeutics' Shares Outstanding (Weighted Average) soared by 3921.1% in 2024, and later skyrocketed by 479287.96% in 2025.
  • Over the past 3 years, Camp4 Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $394976.0 in 2023, then skyrocketed by 1087.44% to $4.7 million in 2024, then skyrocketed by 481.54% to $27.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $27.3 million in Q3 2025, compared to $20.2 million in Q2 2025 and $20.2 million in Q1 2025.